The Scientific Evidence is Key

When choosing any supplement, including Rosehip, it’s important that you do your research. It’s true that Rosehip has been used for centuries as an ingredient in skincare and more recently as a supplement for joint pain. But how do you know if a supplement can really deliver on its promise?

In a word: SCIENCE.

We’re not just talking about reading the label here. When evaluating the science which supports a product, it’s important to ascertain the level of testing, with the most detailed level being double-blind placebo controlled clinical trials. These trials are then published in independent peer-reviewed medical, pharmacology and health journals.

Rose-Hip Vital® Canine is supported by over 30 scientific papers including 9 clinical trials, unique to Rose-Hip Vital® products, which have been published in peer reviewed journals internationally. It has the same active constituent as Rose-Hip Vital® for humans and the brand is now acknowledged as the leader in the field of manufactured Rosehip.

Robin Christensen, respected international researcher and author of Rosehip Meta-analysis, emphasises that it is only the Rosehip powder in Rose-Hip Vital® products that has been the subject of testing in clinical trials and is the only product in the world which contains the patented active compound.

Here are a few of the scientific trials published in notable clinical peer-reviewed journals or presented at international medical meetings, highlighting the effectiveness of Rose-Hip Vital® with GOPO®:

Results from a randomized, placebo-controlled trial published in the Osteoarthritis and Cartilage 18, supplement 2 (2010) suggests Rose-Hip Vital® Canine shows anti-inflammatory properties in dogs and works as a strong antioxidant. The study showed statistically significant improvements to the general wellbeing of dogs, with the study testing for motivation, mood, working capacity, cooperation, speed and fur quality. Three-month treatment resulted in a significant decline in total white blood cell count – indicating that Rose-Hip Vital® Canine works as an anti-inflammatory in dogs.

OARSI 2010

Rosehip has been the subject of a significant new study published in the of medical journal Phytomedicine – Rosehip herbal remedy in patients with Rheumatoid Arthritis – a randomised controlled trial – which has shown that patients with Rheumatoid Arthritis may benefit from additional treatment with Rosehip powder with GOPO®.


Further evidence of the effectiveness of GOPO® on chronic joint conditions has been reported by the Phytomedicine Journal of 2004; 66% of patients taking GOPO® reported a reduction in joint pain. Interestingly, patients also reported an improvement in general wellbeing, including mood, sleep quality and energy.


A presentation by Joseph Schwager, Phd, at the APLAR conference Asia Pacific League of Associations for Rheumatology conference in Japan titled The Galactolipid GOPO® Mediates Beneficial Effects of Rose Hip on Arthritis by Reducing Chemokine and Interleukin Production in Macrophages and Chondrocytes, showed that an active compound, when isolated from the Rosehip, may play a role in assisting in the rebuilding and protection of cartilage.

APLAR 2008

A study released by Arasalan Kharazmi, Phd, at OARSI (Osteoarthritis Research Society International) – Laboratory and preclinical studies on the anti-inflammatory and anti-oxidant properties of rosehip powder – Identification and characterisation of the active component GOPO® - demonstrate through assessment of in vitro studies that rosehip powder exhibits anti-inflammatory as well as anti-oxidant activities.

OARSI 2008

For a full set of scientific studies and presentations see our Scientific Research page.